参考文献/References:
[1] Fong DS, Aiello LP, Ferris FL 3rd, et al.Diabetic retinopathy [J].Diabetes Care,2004,27(10):2540-2553.DOI:10.2337/diacare.27.10.2540.
[2] Al-Shabrawey M, Zhang W, McDonald D. Diabetic retinopathy:mechanism, diagnosis, prevention, and treatment [J].Biomed Res Int,2015,2015:854593.DOI:10.1155/2015/854593.
[3] Wang W,Lo ACY. Diabetic retinopathy:pathophysiology and treatments [J].Int J Mol Sci,2018,19(6):1816.DOI:10.3390/ijms19061816.
[4] Romere C, Duerrschmid C, Bournat J, et al. Asprosin, a fasting-induced glucogenic protein hormone [J].Cell,2016,165(3):566-579.DOI:10.1016/j.cell.2016.02.063.
[5] Zhang L, Chen C, Zhou N, et al. Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride [J].Clin Chim Acta,2019,489:183-188.DOI:10.1016/j.cca.2017.10.034.
[6] Li X, Liao M,Shen R,et al.Plasma asprosin levels are associated with glucose metabolism, lipid, and sex hormone profiles in females with metabolic-related diseases [J].Mediators Inflamm,2018,2018:7375294.DOI:10.1155/2018/7375294.
[7] Zhang X, Jiang H, Ma X,et al. Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus [J].J Diabetes Investig,2019,11(2):349-355.DOI:10.1111/jdi.13148.
[8] Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severityscales [J].Ophthalmology, 2003, 110(9):1677-1682.DOI:10.1016/S0161-6420(03)00475-5.
[9] Lee T, Yun S, Jeong JH, et al. Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation [J].Mol Cell Endocrinol,2019,486:96-104.DOI:10.1016/j.mce.2019.03.001.
[10] Jung TW, Kim HC, Kim HU, et al.Asprosin attenuates insulin signaling pathway through PKCδ-activated ER stress and inflammation in skeletal muscle [J].J Cell Physiol,2019, 234(11):20888-20899.DOI:10.1002/jcp.28694.
[11] Wang Y, Qu H, Xiong X, et al. Plasma asprosin concentrations are increased in individuals with glucose dysregulation and correlated with insulin resistance and first-phase insulin secretion [J].Mediators Inflamm,2018,2018:9471583.DOI:10.1155/2018/9471583.
[12] Groener JB, Valkanou A, Kender Z, et al. Asprosin response in hypoglycemia is not related to hypoglycemia unawareness but rather to insulin resistance in type 1 diabetes [J].PLoS One,2019,14(9):e0222771.DOI:10.1371/journal.pone.0222771.
[13] Baykus Y, Yavuzkir S, Ustebay S, et al. Asprosin in umbilical cord of newborns and maternal blood of gestational diabetes, preeclampsia, severe preeclampsia, intrauterine growth retardation and macrosemic fetus [J].Peptides,2019,120:170132.DOI:10.1016/j.peptides.2019.170132.
[14] Acara AC, Bolatkale M, Kzlogˇlu , et al. A novel biochemical marker for predicting the severity of ACS with unstable angina pectoris:asprosin [J].Am J Emerg Med,2018,36(8):1504-1505.DOI:10.1016/j.ajem.2017.12.032.
相似文献/References:
[1]苏月,王洁,于珮.血浆纤维蛋白原在糖尿病视网膜病变
患者中的水平及意义[J].国际内分泌代谢杂志,2016,36(01):1.[doi:10.3760/cma.j.issn.1673-4157.2016.01.001]
Su Yue,Wang Jie,Yu Pei..Level of plasma fibrinogen in patients with diabetic retinopathy and its significance[J].International Journal of Endocrinology and Metabolism,2016,36(06):1.[doi:10.3760/cma.j.issn.1673-4157.2016.01.001]
[2]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白
与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[3]高璐,信中,袁明霞,等.代谢综合征与糖尿病及糖尿病前期人群
糖尿病视网膜病变的相关性分析[J].国际内分泌代谢杂志,2017,37(05):298.
Gao Lu*,Xin Zhong,Yuan Mingxia,et al.A study on correlation between metabolic syndrome and diabetic retinopathy in diabetic and pre-diabetic people[J].International Journal of Endocrinology and Metabolism,2017,37(06):298.
[4]刘晓妮 王颖 李桃桃 马小敏 梁彦.血管紧张素转换酶基因rs4353多态性
与糖尿病微血管病变的相关性研究[J].国际内分泌代谢杂志,2018,38(03):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
Liu Xiaoni*,Wang Ying,Li Taotao,et al.Association between angiotensin converting enzyme gene rs4353 polymorphism and diabetic microangiopathy[J].International Journal of Endocrinology and Metabolism,2018,38(06):149.[doi:10.3760/cma.j.issn.1673-4157.2018.03.002]
[5]毕会利 张慧娟.信号素3家族与糖尿病及其微血管并发症[J].国际内分泌代谢杂志,2018,38(02):110.[doi:10.3760/cma.j.issn.1673-4157.2018.02.010]
Bi Huili,Zhang Huijuan..Class 3 semaphorins in diabetes mellitus and its microvascular complications[J].International Journal of Endocrinology and Metabolism,2018,38(06):110.[doi:10.3760/cma.j.issn.1673-4157.2018.02.010]
[6]张博 李凤君 左中夫.生长抑素对糖尿病大鼠视网膜病变的神经
保护作用及对GFAP、突触素表达的影响[J].国际内分泌代谢杂志,2018,38(06):370.[doi:10.3760/cma.j.issn.1673-4157.2018.06.003]
Zhang Bo*,Li Fengjun,Zuo Zhongfu.The neuroprotection of somatostatin and its effects on the expression of GFAP and synaptophysin in rats with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2018,38(06):370.[doi:10.3760/cma.j.issn.1673-4157.2018.06.003]
[7]韩秀丹 朱凌燕 徐积兄.二甲双胍对糖尿病视网膜病变的作用及机制[J].国际内分泌代谢杂志,2019,39(01):53.[doi:10.3760/cma.j.issn.1673-4157.2019.01.013]
Han Xiudan,Zhu Lingyan,Xu Jixiong.Effects of metformin on diabetic retinopathy and its mechanism[J].International Journal of Endocrinology and Metabolism,2019,39(06):53.[doi:10.3760/cma.j.issn.1673-4157.2019.01.013]
[8]俞冰鸿 杨菊红 单春艳.阻塞性睡眠呼吸暂停低通气综合征与糖尿病
视网膜病变的关系[J].国际内分泌代谢杂志,2019,39(04):269.[doi:10.3760/cma.j.issn.1673-4157.2019.04.013]
Yu Binghong,Yang Juhong,Shan Chunyan.Relationship between obstructive sleep apnea syndrome and diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2019,39(06):269.[doi:10.3760/cma.j.issn.1673-4157.2019.04.013]
[9]孙梅 刘栩晗 王冰 高政南.吸烟与中老年糖尿病患者视网膜病变的
相关性研究[J].国际内分泌代谢杂志,2020,40(04):223.[doi:10.3760/cma.j.issn.1673-4157.2020.04.002]
Sun Mei,Liu Xuhan,Wang Bing,et al.Study on the correlation between smoking and diabetic retinopathy in middle-age and old people[J].International Journal of Endocrinology and Metabolism,2020,40(06):223.[doi:10.3760/cma.j.issn.1673-4157.2020.04.002]
[10]董荣娜,李晶.人工智能在糖尿病视网膜病变诊断中应用的研究进展[J].国际内分泌代谢杂志,2020,40(06):412.[doi:10.3760/cma.j.cn121383-20200328-03075]
Dong Rongna,Li Jing.Advances in the application of artificial intelligence in the diagnosis of diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2020,40(06):412.[doi:10.3760/cma.j.cn121383-20200328-03075]